cancer_statistics
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
cancer_statistics [2020/02/28 13:02] trynke [Table] |
cancer_statistics [2025/02/05 14:49] (current) |
||
|---|---|---|---|
| Line 4: | Line 4: | ||
| - | | **Type** | **At Baseline** | **New cases** | | + | | **Type** | **At Baseline** | **New cases** | |
| - | | | [[1A]] | [[1B]][[1C]][[2A]] | | + | | | [[1A]] | [[1B]] - [[1C]] - [[2A]] | |
| - | | Cancer general | 7000 | 2400 | | + | | Cancer general | 7000 | 2400 | |
| - | | skin cancer | 2500 | 890 | | + | | skin cancer | 2500 | 890 | |
| - | | breast cancer | 1300 | 480 | | + | | breast cancer | 1300 | 480 | |
| - | | endometrial cancer | 670 | 65 | | + | | endometrial cancer | 670 | 65 | |
| - | | ovarian cancer | 95 | 27 | | + | | ovarian cancer | 95 | 27 | |
| - | | vaginal and vulvar cancer | 10 | <10 | | + | | vaginal and vulvar cancer | 10 | <10 | |
| - | | lung cancer | 65 | 60 | | + | | lung cancer | 65 | 60 | |
| - | | head/neck cancer excl. eye and salivary glands | 95 | 15 | | + | | head/neck cancer excl. eye and salivary glands | 95 | 15 | |
| - | | eye cancer | 10 | <10 | | + | | eye cancer | 10 | <10 | |
| - | | salivary gland cancer | 20 | <10 | | + | | salivary gland cancer | 20 | <10 | |
| - | | central nervous system cancer | 80 | 40 | | + | | central nervous system cancer | 80 | 40 | |
| - | | prostate cancer | 320 | 245 | | + | | prostate cancer | 320 | 245 | |
| - | | penile cancer | <10 | <10 | | + | | penile cancer | <10 | <10 | |
| - | | testis cancer | 200 | 20 | | + | | testis cancer | 200 | 20 | |
| - | | urinary tract and bladder cancer | 110 | 55 | | + | | urinary tract and bladder cancer | 110 | 55 | |
| - | | bowel cancer | 340 | 170 | | + | | bowel cancer | 340 | 170 | |
| - | | oesophageal cancer | 20 | 25 | | + | | oesophageal cancer | 20 | 25 | |
| - | | stomach cancer | 15 | 10 | | + | | stomach cancer | 15 | 10 | |
| - | | pancreas cancer | 10 | 15 | | + | | pancreas cancer | 10 | 15 | |
| - | | gallbladder cancer | <10 | <10 | | + | | gallbladder cancer | <10 | <10 | |
| - | | other digestive tract cancer | <10 | <10 | | + | | other digestive tract cancer | <10 | <10 | |
| - | | liver cancer | 15 | 10 | | + | | liver cancer | 15 | 10 | |
| - | | thyroid cancer | 100 | 20 | | + | | thyroid cancer | 100 | 20 | |
| - | | bone and soft tissue cancer | 90 | 35 | | + | | bone and soft tissue cancer | 90 | 35 | |
| - | | plasma cell cancer | 20 | 15 | | + | | plasma cell cancer | 20 | 15 | |
| - | | other haematological cancer | <10 | <10 | | + | | other haematological cancer | <10 | <10 | |
| - | | kidney cancer | 85 | 45 | | + | | kidney cancer | 85 | 45 | |
| - | | leukemia | 100 | 55 | | + | | leukemia | 100 | 55 | |
| - | | lymphoma | 225 | 60 | | + | | lymphoma | 225 | 60 | |
| - | | prestage cancer | 320 | 85 | | + | | prestage cancer | 320 | 85 | |
| - | | unknown if it is cancer | 115 | <10 | | + | | unknown if it is cancer | 115 | <10 | |
| - | | cancer, but location unknown | 90 | 30 | | + | | cancer, but location unknown | 90 | 30 | |
| - | | | | | | + | | certainly no cancer | 145526 | | |
| ====Smoking amongst participant with cancer at baseline==== | ====Smoking amongst participant with cancer at baseline==== | ||
| Line 45: | Line 45: | ||
| | ** Smoking frequency amongst cancer patients** | **Participants with cancer** | **Participants without cancer** | | | ** Smoking frequency amongst cancer patients** | **Participants with cancer** | **Participants without cancer** | | ||
| - | | **Smokers** | 1155 (16,9%) | 30046 (21,6%) | | + | | **Smokers** | ~1150 (17%) | ~30,000 (22%) | |
| - | | **Non-smokers** | 5690 (83,1%) | 109325 (78.4%) | | + | | **Non-smokers** | ~5700 (83%) | ~110.000 (78%) | |
| - | | **Total** | 6845 | 139371 | | + | | **Total** | ~6850 | ~140,000 | |
cancer_statistics.1582891333.txt.gz · Last modified: 2025/02/05 14:49 (external edit)
Page Tools
Except where otherwise noted, content on this wiki is licensed under the following license: CC Attribution-Noncommercial-Share Alike 4.0 International
